Unparalleled Air Purification for Hospitals
LifeAire's® patented air purification for hospitals provides a 24x7 kill/remediation of all airborne bacterial, fungal and viral pathogens
LifeAire combines HEPA’s unparalleled particulate capture with next generation pathogen kill in a single pass with a VOC reduction to <100 ppb.
PROBLEMS
- The CDC estimates that 15% to 45% of HAIs are caused by airborne pathogens. (cdc.gov/nhsn/hai-report/narrative-commentary.html)
- HAIs cost hospital $28.4 Billion annually with airborne pathogens accounting for $4.2 billion.
(cdc.gov/policy/polaris/healthtopics/hai/index.html) - 43% of US Hospitals have been penalized for HACs/HAIs
(fiercehealthcare.com/hospitals/medicare-fines)
LifeAire’s Patented AIRE~HCX®II System kills up to 100% of airborne biologicals including: MRSA, Clostridioides difficile, Influenza virus, Mycobacterium tuberculosis, RSV, Rubeola, and SARS-COV-2 + others in a single pass.
Multi-Stage Purification
- Enhances HEPA filtration by removing chemicals and killing biological pathogens.
- Exceeds ASHRAE 241 standards for air quality.
- Prevents pathogen proliferation and contamination.
- Continuous protection, even during clinical activity.
- Delivers dynamic 9-log pathogen reduction.
- Study shows 94% reduction of surface pathogens.
(450 CFU/in2 on the control floor and 25 CFU/in2 in the LifeAire zone) S.P. Stawicki et al. / Surgery 168 (2020) 968e974
AIRE~HCX®II delivers a VOC Reduction of <100ppb and a 100% Single Pass Kill Rate for the most common viral and biological pathogens
All Data Provided Is 3rd Party Tested & Published in Peer Reviewed Journals:
- Pennsylvania State Univ. IEC Lab (Oct 2011)
- Tested by National Homeland Security
Research Center of the EPA - ASHRAE (Oct 2023)
- J. Global Infectious Diseases (May 2023)
- Journal of Gerontology (2023)
- ASHRAE (June 2022)
- Journal of Surgery (Sept 2020)
- Vignettes in Patient Safety Vol 4, Ch. 8 (2019)
- Two Peer Reviewed ROI and IRR related
studies showing < 6-month payback.
Air purification for hospitals, designed to protect the most demanding, sensitive clinical healthcare environments in the world
The LifeAire System was initially designed to protect the environment of the human embryo in the In Vitro Fertilization laboratory (one of the most sensitive cells to culture in vitro).
This meant that it was critical that the system remediate all chemical and biological contaminants from the air. Therefore, the LifeAire System was engineered to kill the anthrax spore, the most difficult biological to kill.
Because of its effectiveness towards the anthrax spore, the LifeAire System is able to remediate airborne pathogens such as clostridium difficile, MRSA, aspergillus, influenza, TB, streptococcus, COVID-19, etc., each representing a consistent threat to both the hospital environment and hospital acquired infection (HAI) rate.
Today, it is a recognized leader in providing advanced air purification for hospitals, healthcare facilities, IVF programs, and many other applications.
Aire~HCX®
Hospitals & Healthcare
Product Highlights
- Kills in a Single Pass
- Multiple Sizes Available
- New & Retrofit Applications
- In-Duct and All Weather Systems
Product Achievements
- Reduction of hospital acquired infections (HAI) and readmission rates
- 39% reduction in patient length of stay (LOS) in a leading hospital network
- 23% improved per bed economics
- 97% reduction in surface pathogens
- Increased facility capacity and throughput
Aire~VOC
Volatile Organic Compounds
Product Highlights
- Multiple Sizes Available
- New & Retrofit Applications
- In-Duct and All Weather Systems
Aire~LifeLine®
In-Line Gas Filtration
Product Highlights
- In-line air filtration with state-of-the-art protection, delivering the most advanced, and longest, filtering capacity in the market
- Filters Cylinder and House Gasses O2, N2, CO2, & Tri-gas
- Delivers broadest VOC and particulate protection
- Quick connects for easy installation and replacement in existing set-ups.
Get in touch with our team today to learn more about our air purification for hospitals.
The Impact of LifeAire's Air Purification for Hospitals
LifeAire provides advanced air purification for hospitals, removing harmful airborne pathogens and contaminants to reduce the spread of infection and improve patient, and staff, safety. Our system has been installed to protect patient rooms specific to an ICU Medical Surgical floor. The data from 8,255 patients over a one year time period has revealed a reduction in HAIs and readmission rates, a statistically significant decrease in length of stay, improved discharge metrics and overall savings to the hospital. The data has been published in the journal, Surgery. Similarly, the System has been installed to protect the residents on a single floor in a leading senior living facility.
The first 9 months of data demonstrated a statistically significant reduction (39.7%) in HAIs over the control floor. This data is also being prepared for publication in a leading LTC journal. A study, published in The Journals of Gerontology (May 2023), focused on the effects of an advanced air purification technology (AAPT) on environmental and clinical outcomes in a long-term care facility. Click here to learn more and request a copy of the research.
The data has been published in the journal, Surgery. Click here to view this research.
LifeAire has a deep commitment to air purity.
– Bill Moyer, West Region President for St. Luke's University Health Network and President of St. Luke Allentown Campus
What are others saying about LifeAire?
LifeAire Air Purification for Hospitals, used by the world's leading healthcare organizations
LifeAire Systems Healthcare & Hospital News
LifeAire Systems Additional Resources
John Nespoli, President, St. Luke’s University Health Network Carbon County Campuses
LifeAire Systems’ advanced air purification technology is helping protect a children’s ER
We value your privacy. Your information will not be shared or sold. We will only contact you regarding your specific request.